TrialJournal of inherited metabolic disease2025

Safety and Efficacy of DTX401, an AAV8-Mediated Liver-Directed Gene Therapy, in Adults With Glycogen Storage Disease Type I a (GSDIa).

David A Weinstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.